Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     In Vitro Diagnostics     Clinical Chemistry     Clinical Chemistry Instruments/Analyzer    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

Asia-Pacific Clinical Chemistry Instruments/Analyzer - Analysis and Forecast to 2019

  • Report Code: CL 1001
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

Clinical chemistry is the application of chemical, molecular, and cellular concepts and techniques to understand and evaluate the human health. Routine tests including testing for blood albumin, ALT/SGPT, ammonia, blood gases, and calcium and creatinine levels are required before undergoing advanced tests. Clinical chemistry tests thus form the center stage of the IVD market. The significant changes in this sector have been brought about as a result of the convergence of system engineering, automation, and IT technology. Thus, the new technologies have enabled a better understanding of disease processes.

The clinical chemistry market is expanding, consolidating, and becoming highly competitive with a myriad of opportunities for various new instruments, reagents, calibrators, and other systems. The largest segment of clinical chemistry is the general chemistry testing of the clinical chemistry market.

The introduction of user-friendly automated devices has minimized the human efforts and increased the efficiency of diagnostic procedures. For instance, the Ortho Clinical Vitros 350 Chemistry System accommodates up to 40 samples in one of its four trays, allowing laboratories to effectively meet the testing needs of the patient population. These systems, with their enhanced software and elaborate menu, are responsible for the speeding up of the treatment process at lower costs.

The key players of this market are Siemens, Abbott Laboratories, Danaher Corporation, Ortho Clinical Diagnostics, bioMerieux SA, Bio-rad, Alere, Becton Dickinson and Company, and Thermo Fisher Scientific.



1 Introduction
1.1 Objectives Of The Study
1.2 Market Segmentation & Coverage
1.3 Stakeholders
2 Research Methodology
2.1 Integrated Ecosystem Of Clinical Chemistry Instruments/Analyzer Market
2.2 Arriving At The Clinical Chemistry Instruments/Analyzer Market Size
2.2.1 Top-Down Approach
2.2.2 Bottom-Up Approach
2.2.3 Demand Side Approach
2.2.4 Macro Indicator-Based Approach
3 Market Overview
3.1 Introduction
3.2 Asia-Pacific Clinical Chemistry Instruments/Analyzer Market: Comparison With Parent Market
3.3 Market Drivers And Inhibitors
3.4 Key Market Dynamics
3.5 Demand Side Analysis
3.6 Vendor Side Analysis
4 Competitive Landscape
4.1 Clinical Chemistry Instruments/Analyzer Market: Company Share Analysis
4.2 Company Presence In Clinical Chemistry Instruments/Analyzer Market, By Type
5 Clinical Chemistry Instruments/Analyzer Market, By Company
6 APPENDIX

Please fill in the form below to receive a free copy of the Summary of this Report
















Asia-Pacific Clinical Chemistry Instruments/Analyzer - Analysis and Forecast to 2019

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
North American Clinical Chemistry North American Clinical Chemistry
The North American clinical chemistry market was estimated at $3,852.7 million in 2013 and is expected to reach $5,370.5 million by 2019, at a CAGR of 7.2% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report.
Upcoming
European Clinical Chemistry European Clinical Chemistry
Although earlier, Europe showed a negative growth rate in the clinical chemistry market, in some countries revenues grew compared to 2011. Germany commanded the largest share (20%) at an estimated $652.8 million in 2013 and is expected to reach $853.3 million by 2018, at a CAGR of 5.8% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report.
Upcoming
Asia-Pacific Clinical Chemistry Analyzer Asia-Pacific Clinical Chemistry Analyzer
The Asia-Pacific clinical chemistry market is growing in double digits and will continue to grow in future. China commanded the largest share (53%) at an estimated $516.81 million in 2013 and is expected to reach $1047.2 million by 2018, at a CAGR of 16.0% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report.
Mar 2015
of items
reports | Show
Connect With Us
US/CAN : +1-888-502-0539